Targeting the CLDN-LILRB axis inhibits the activity of immunosuppressive myeloid cells and suppresses tumor progression.
Claudins interact with LILRB immune inhibitory receptors to promote myeloid immunosuppression in cancer | Science Immunology
Targeting the CLDN-LILRB axis inhibits the activity of immunosuppressive myeloid cells and suppresses tumor progression.